A potential cost of evolving epibatidine resistance in poison frogs.

York, Julia M; Borghese, Cecilia M; George, Andrew A; Cannatella, David C; Zakon, Harold H

York, Julia M; Borghese, Cecilia M; George, Andrew A; Cannatella, David C; Zakon, Harold H.

Afiliação

York JM; Department of Neuroscience, The University of Texas, Austin, TX, USA.
Borghese CM; Department of Integrative Biology, and Biodiversity Center, The University of Texas, Austin, TX, USA.
George AA; Department of Neuroscience, The University of Texas, Austin, TX, USA.
Cannatella DC; Department of Neurobiology, The Barrow Neurological Institute, Phoenix, AZ, USA.
Zakon HH; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.

BMC Biol ; 21(1): 144, 2023 06 28.

Article em En | MEDLINE | ID: mdl-37370119

Assuntos

Acetilcolina; Venenos; Humanos; Acetilcolina/farmacologia; Piridinas/farmacologia; Compostos Bicíclicos Heterocíclicos com Pontes/farmacologia

Palavras-chave

Epibatidine; Epipedobates anthonyi; Evolution; Nanorana parkeri; Nicotinic acetylcholine receptor; Poison frog; Xenopus tropicalis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Venenos / Acetilcolina Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google